Elevated homocysteine with pseudo-homozygosity for MTHFR677T as predisposing factors for transient ischemic attacks:

A Sobczyńska-Malefora1, J Cutler2, Y Rahman3

  • 1The Nutristasis Unit, Haemostasis & Thrombosis, Viapath, St. Thomas' Hospital, London, UK. agata.malefora@viapath.co.uk.

Insights

A young man

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Elevated homocysteine levels are linked to neurological events.
  • MTHFR gene variants can impact homocysteine metabolism.

Observation:

  • A 21-year-old male experienced transient neurological events.
  • Brain MRI revealed an infarct; angiogram showed intracranial stenosis.
  • Laboratory tests showed high homocysteine, low folate, and MTHFR gene variants.

Findings:

  • Folic acid treatment normalized homocysteine levels.
  • The patient had MTHFR variants: 677C>T heterozygosity and a c.3G>C substitution.
  • A combination of folate deficiency and MTHFR variants likely caused hyperhomocysteinemia and neurological symptoms.

Implications:

  • This case underscores the importance of investigating MTHFR mutations beyond the 677C>T variant.
  • Early diagnosis and intervention, including folic acid supplementation, are crucial for patients with MTHFR-related hyperhomocysteinemia.
  • Understanding genetic factors in hyperhomocysteinemia can prevent premature cardiovascular events.